GlassScriptPhysician profile
Joann Lohr
NPI 1205802808
$1,997.44
in general payments reported to CMS, 2019-2025
10 companies · $310 in 2025
The $310 reported for 2025 was less than what a typical Vascular Surgery provider received nationally (typical 2025 total: $927).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $763 · 2021: $114 · 2022: $365 · 2023: $180 · 2024: $266 · 2025: $310.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $756.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $756.11 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| W. L. Gore & Associates, INC. | $701.77 | 2019-2025 | Gore Enform Preperitoneal Biomaterial, Gore Viabahn Endoprosthesis |
| Medtronic, INC. | $377.27 | 2022-2024 | Endurant Iis |
| Abbott Laboratories | $311.85 | 2019 | |
| Stryker Corporation | $136.80 | 2025 | Artix Mt |
| Biom'Up France Sas | $113.88 | 2021 | |
| Organogenesis INC. | $109.57 | 2022 | |
| Penumbra, INC. | $98.21 | 2025 | Indigo System |
| Inari Medical, INC. | $87.00 | 2024 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Boston Scientific Corporation | $57.09 | 2022 | |
| Polarityte, INC. | $4.00 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joann Lohr listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.